Biopharmaceutical and Vaccine Production Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: BC8F610AFCD3EN
Market Monitor Global

Abstracts

Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

This report contains market size and forecasts of Biopharmaceutical and Vaccine Production in Global, including the following market information:

Global Biopharmaceutical and Vaccine Production Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biopharmaceutical and Vaccine Production market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biopharmaceutical Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biopharmaceutical and Vaccine Production include Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceutical and Vaccine Production companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biopharmaceutical and Vaccine Production Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Type, 2021 (%)

• Biopharmaceutical
• Vaccine Production

Global Biopharmaceutical and Vaccine Production Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical
• Biotechnology
• Academic and Research Institutes
• Others

Global Biopharmaceutical and Vaccine Production Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biopharmaceutical and Vaccine Production Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biopharmaceutical and Vaccine Production revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biopharmaceutical and Vaccine Production revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• Sanofi
• Roche
• Abbott
• Regeneron Pharmaceuticals
• Alexion Pharmaceuticals
• Johnson and Johnson
• GlaxoSmithKline
• Merck
• Lonza
• FUJIFILM Diosynth Biotechnologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biopharmaceutical and Vaccine Production Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biopharmaceutical and Vaccine Production Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOPHARMACEUTICAL AND VACCINE PRODUCTION OVERALL MARKET SIZE

2.1 Global Biopharmaceutical and Vaccine Production Market Size: 2021 VS 2028
2.2 Global Biopharmaceutical and Vaccine Production Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biopharmaceutical and Vaccine Production Players in Global Market
3.2 Top Global Biopharmaceutical and Vaccine Production Companies Ranked by Revenue
3.3 Global Biopharmaceutical and Vaccine Production Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceutical and Vaccine Production Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biopharmaceutical and Vaccine Production Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Players in Global Market
  3.6.1 List of Global Tier 1 Biopharmaceutical and Vaccine Production Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biopharmaceutical and Vaccine Production Market Size Markets, 2021 & 2028
  4.1.2 Biopharmaceutical
  4.1.3 Vaccine Production
4.2 By Type - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
  4.2.1 By Type - Global Biopharmaceutical and Vaccine Production Revenue, 2017-2022
  4.2.2 By Type - Global Biopharmaceutical and Vaccine Production Revenue, 2023-2028
  4.2.3 By Type - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biopharmaceutical and Vaccine Production Market Size, 2021 & 2028
  5.1.2 Pharmaceutical
  5.1.3 Biotechnology
  5.1.4 Academic and Research Institutes
  5.1.5 Others
5.2 By Application - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
  5.2.1 By Application - Global Biopharmaceutical and Vaccine Production Revenue, 2017-2022
  5.2.2 By Application - Global Biopharmaceutical and Vaccine Production Revenue, 2023-2028
  5.2.3 By Application - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biopharmaceutical and Vaccine Production Market Size, 2021 & 2028
6.2 By Region - Global Biopharmaceutical and Vaccine Production Revenue & Forecasts
  6.2.1 By Region - Global Biopharmaceutical and Vaccine Production Revenue, 2017-2022
  6.2.2 By Region - Global Biopharmaceutical and Vaccine Production Revenue, 2023-2028
  6.2.3 By Region - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biopharmaceutical and Vaccine Production Revenue, 2017-2028
  6.3.2 US Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.3.3 Canada Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.3.4 Mexico Biopharmaceutical and Vaccine Production Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biopharmaceutical and Vaccine Production Revenue, 2017-2028
  6.4.2 Germany Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.3 France Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.4 U.K. Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.5 Italy Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.6 Russia Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.7 Nordic Countries Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.4.8 Benelux Biopharmaceutical and Vaccine Production Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biopharmaceutical and Vaccine Production Revenue, 2017-2028
  6.5.2 China Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.5.3 Japan Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.5.4 South Korea Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.5.5 Southeast Asia Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.5.6 India Biopharmaceutical and Vaccine Production Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biopharmaceutical and Vaccine Production Revenue, 2017-2028
  6.6.2 Brazil Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.6.3 Argentina Biopharmaceutical and Vaccine Production Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, 2017-2028
  6.7.2 Turkey Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.7.3 Israel Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.7.4 Saudi Arabia Biopharmaceutical and Vaccine Production Market Size, 2017-2028
  6.7.5 UAE Biopharmaceutical and Vaccine Production Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Biopharmaceutical and Vaccine Production Major Product Offerings
  7.1.4 Novartis Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Biopharmaceutical and Vaccine Production Major Product Offerings
  7.2.4 Pfizer Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Biopharmaceutical and Vaccine Production Major Product Offerings
  7.3.4 Sanofi Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Biopharmaceutical and Vaccine Production Major Product Offerings
  7.4.4 Roche Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Biopharmaceutical and Vaccine Production Major Product Offerings
  7.5.4 Abbott Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.5.5 Abbott Key News
7.6 Regeneron Pharmaceuticals
  7.6.1 Regeneron Pharmaceuticals Corporate Summary
  7.6.2 Regeneron Pharmaceuticals Business Overview
  7.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Major Product Offerings
  7.6.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.6.5 Regeneron Pharmaceuticals Key News
7.7 Alexion Pharmaceuticals
  7.7.1 Alexion Pharmaceuticals Corporate Summary
  7.7.2 Alexion Pharmaceuticals Business Overview
  7.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Major Product Offerings
  7.7.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.7.5 Alexion Pharmaceuticals Key News
7.8 Johnson and Johnson
  7.8.1 Johnson and Johnson Corporate Summary
  7.8.2 Johnson and Johnson Business Overview
  7.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Major Product Offerings
  7.8.4 Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.8.5 Johnson and Johnson Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Major Product Offerings
  7.9.4 GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Biopharmaceutical and Vaccine Production Major Product Offerings
  7.10.4 Merck Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News
7.11 Lonza
  7.11.1 Lonza Corporate Summary
  7.11.2 Lonza Business Overview
  7.11.3 Lonza Biopharmaceutical and Vaccine Production Major Product Offerings
  7.11.4 Lonza Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.11.5 Lonza Key News
7.12 FUJIFILM Diosynth Biotechnologies
  7.12.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
  7.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
  7.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Major Product Offerings
  7.12.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue in Global Market (2017-2022)
  7.12.5 FUJIFILM Diosynth Biotechnologies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biopharmaceutical and Vaccine Production Market Opportunities & Trends in Global Market
Table 2. Biopharmaceutical and Vaccine Production Market Drivers in Global Market
Table 3. Biopharmaceutical and Vaccine Production Market Restraints in Global Market
Table 4. Key Players of Biopharmaceutical and Vaccine Production in Global Market
Table 5. Top Biopharmaceutical and Vaccine Production Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biopharmaceutical and Vaccine Production Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biopharmaceutical and Vaccine Production Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biopharmaceutical and Vaccine Production Product Type
Table 9. List of Global Tier 1 Biopharmaceutical and Vaccine Production Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical and Vaccine Production Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biopharmaceutical and Vaccine Production Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biopharmaceutical and Vaccine Production Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biopharmaceutical and Vaccine Production Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Biopharmaceutical and Vaccine Production Product Offerings
Table 32. Novartis Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Biopharmaceutical and Vaccine Production Product Offerings
Table 35. Pfizer Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Biopharmaceutical and Vaccine Production Product Offerings
Table 38. Sanofi Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Biopharmaceutical and Vaccine Production Product Offerings
Table 41. Roche Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Biopharmaceutical and Vaccine Production Product Offerings
Table 44. Abbott Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 45. Regeneron Pharmaceuticals Corporate Summary
Table 46. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product Offerings
Table 47. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 48. Alexion Pharmaceuticals Corporate Summary
Table 49. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product Offerings
Table 50. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Biopharmaceutical and Vaccine Production Product Offerings
Table 53. Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product Offerings
Table 56. GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Biopharmaceutical and Vaccine Production Product Offerings
Table 59. Merck Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 60. Lonza Corporate Summary
Table 61. Lonza Biopharmaceutical and Vaccine Production Product Offerings
Table 62. Lonza Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)
Table 63. FUJIFILM Diosynth Biotechnologies Corporate Summary
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product Offerings
Table 65. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biopharmaceutical and Vaccine Production Segment by Type in 2021
Figure 2. Biopharmaceutical and Vaccine Production Segment by Application in 2021
Figure 3. Global Biopharmaceutical and Vaccine Production Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical and Vaccine Production Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biopharmaceutical and Vaccine Production Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2021
Figure 8. By Type - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 12. US Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 16. Germany Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 17. France Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 24. China Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 28. India Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 30. Brazil Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biopharmaceutical and Vaccine Production Revenue Market Share, 2017-2028
Figure 33. Turkey Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biopharmaceutical and Vaccine Production Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Lonza Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue Year Over Year Growth (US$, Mn) & (2017-2022)